Quidelortho (QDEL) closed at $10.74 on November 13, 2026, up 1.1% from the previous close, on volume of 1,981,653 shares (30-day average 2,370,682).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 15, 2026 | Put Diagonal Ratio Spread | 19-Mar-27 25[119x]|17-Jun-27 22.5[145x] P | 264 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
QuidelOrtho Earnings Call Signals Pressure and Profit Recovery
TipRanks (Sun, 15-Nov 7:06 PM ET)
Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 12-Nov 12:15 PM ET)
Globe Newswire (Thu, 12-Nov 10:10 AM ET)
Business Wire (Wed, 11-Nov 1:38 PM ET)
QDEL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into QuidelOrtho (QDEL)
ACCESS Newswire (Wed, 11-Nov 10:10 AM ET)
PRNewswire (Tue, 10-Nov 10:14 AM ET)
PRNewswire (Mon, 9-Nov 5:35 PM ET)
QuidelOrtho Reports Third Quarter 2026 Financial Results
PRNewswire (Tue, 3-Nov 4:05 PM ET)
Transforming Data Into Actionable Insights in the Lab
PRNewswire (Thu, 29-Oct 3:27 PM ET)
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
PRNewswire (Tue, 20-Oct 8:01 AM ET)
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Quidelortho trades on the NASDAQ stock market under the symbol QDEL.
As of November 13, 2026, QDEL stock price climbed to $10.74 with 1,981,653 million shares trading.
QDEL has a beta of 1.15, meaning it tends to be more sensitive to market movements. QDEL has a correlation of 0.03 to the broad based SPY ETF.
QDEL has a market cap of $731.20 million. This is considered a Small Cap stock.
Last quarter Quidelortho reported $619 million in Revenue and $.31 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.13.
In the last 3 years, QDEL traded as high as $75.86 and as low as $9.92.
The top ETF exchange traded funds that QDEL belongs to (by Net Assets): IJR, AVUV, VTI, IWM, VB.
QDEL has underperformed the market in the last year with a price return of -51.6% while the SPY ETF gained +13.4%. QDEL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.8% and -18.9%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
QDEL support price is $9.92 and resistance is $11.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QDEL shares will trade within this expected range on the day.